Us Bancorp \De\ Denali Therapeutics Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,168 shares of DNLI stock, worth $28,616. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,168

Previous 1,616 27.72%

Holding current value

$28,616

Previous $37,000 8.11%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$20.96 - $31.05 $9,390 - $13,910	-448 Reduced 27.72%	1,168 $34,000
Q2 2024 Aug 06, 2024	BUY	$14.96 - $23.22 $12,910 - $20,038	863 Added 114.61%	1,616 $37,000
Q1 2024 May 07, 2024	BUY	$15.83 - $23.35 $4,020 - $5,930	254 Added 50.9%	753 $15,000
Q4 2023 Feb 09, 2024	SELL	$16.2 - $23.18 $5,524 - $7,904	-341 Reduced 40.6%	499 $10,000
Q3 2023 Nov 03, 2023	BUY	$20.63 - $30.17 $5,260 - $7,693	255 Added 43.59%	840 $17,000
Q2 2023 Aug 09, 2023	SELL	$23.37 - $32.96 $1,659 - $2,340	-71 Reduced 10.82%	585 $17,000
Q1 2023 May 09, 2023	BUY	$21.91 - $32.67 $4,360 - $6,501	199 Added 43.54%	656 $15,000
Q4 2022 Feb 13, 2023	SELL	$26.28 - $33.92 $1,208 - $1,560	-46 Reduced 9.15%	457 $12,000
Q3 2022 Oct 27, 2022	BUY	$25.97 - $38.53 $1,194 - $1,772	46 Added 10.07%	503 $15,000
Q2 2022 Aug 01, 2022	SELL	$20.88 - $35.19 $2,129 - $3,589	-102 Reduced 18.25%	457 $13,000
Q1 2022 May 11, 2022	BUY	$29.0 - $47.27 $3,335 - $5,436	115 Added 25.9%	559 $18,000
Q4 2021 Feb 11, 2022	BUY	$42.59 - $55.02 $255 - $330	6 Added 1.37%	444 $20,000
Q3 2021 Nov 10, 2021	SELL	$48.48 - $78.23 $1,939 - $3,129	-40 Reduced 8.37%	438 $22,000
Q2 2021 Aug 05, 2021	BUY	$50.3 - $78.44 $603 - $941	12 Added 2.58%	478 $37,000
Q1 2021 Apr 28, 2021	BUY	$53.8 - $81.53 $3,819 - $5,788	71 Added 17.97%	466 $27,000
Q4 2020 Feb 04, 2021	BUY	$36.89 - $93.56 $9,370 - $23,764	254 Added 180.14%	395 $33,000
Q3 2020 Nov 10, 2020	BUY	$23.13 - $38.84 $1,318 - $2,213	57 Added 67.86%	141 $5,000
Q2 2020 Aug 07, 2020	BUY	$16.01 - $28.82 $1,344 - $2,420	84 New	84 $2,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.29B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account